Grace's Library

Grace's Library

Understanding GLP-1 Medications

GLP-1 medications are a class of medication your provider may talk with you about. This page is a gentle overview so the words feel a little more familiar — it isn't a recommendation, and it isn't a substitute for a conversation with your care team.

What GLP-1 refers to

GLP-1 stands for a hormone your body already makes. Medications in this class work with pathways your body naturally uses. There are several medications in the class, and providers consider them for different reasons.

Why a provider may consider one

Providers consider GLP-1 medications for a range of health reasons. Whether one is appropriate depends on your full health picture — something only you and your provider can weigh together.

Experiences vary

People respond differently. Some notice changes quickly, others more gradually, and some experience side effects. None of that says anything about your worth or your effort — it's simply information for you and your provider to work through together.

The role of your provider

Decisions about starting, adjusting, or stopping any medication belong with your provider. Grace & Grit is here to help you feel supported and informed — not to replace medical guidance.

Grace's Thoughts

Whatever tools support your wellness — medication, movement, nourishment, rest — they are just tools. Your worth is not tied to any of them.

Questions you may consider asking

  • Is a GLP-1 medication something worth considering for me?
  • What would we be hoping this helps with?
  • What side effects should I watch for?
  • How would we monitor how it's going?
  • What would we do if it isn't the right fit?

Sources & References

The information on this page is drawn from the sources below.

  1. 1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. Insulin, Medicines, & Other Diabetes Treatments.
    https://www.niddk.nih.gov/health-information/diabetes/overview/insulin-medicines-treatments
  2. 2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. Prescription Medications to Treat Overweight & Obesity.
    https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
  3. 3. U.S. Food and Drug Administration (FDA). Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss.
    https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
  4. 4. Drucker DJ. Cell Metabolism, 2018 (PMID 29617641). Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.
    https://pubmed.ncbi.nlm.nih.gov/29617641/

This is educational, not medical advice. Always talk with your provider about what's right for you.